Cargando…
Lipohypertrophy: prevalence, clinical consequence, and pathogenesis
Autores principales: | Xu, Xiao-Han, Carvalho, Vladmir, Wang, Xiao-Hang, Qiu, Shan-Hu, Sun, Zi-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862817/ https://www.ncbi.nlm.nih.gov/pubmed/32810044 http://dx.doi.org/10.1097/CM9.0000000000000970 |
Ejemplares similares
-
Insulin lipodystrophy and lipohypertrophy
por: Mokta, Jatinder K., et al.
Publicado: (2013) -
Gender Differences in Prevalence and Clinical Correlates of Lipohypertrophy in Insulin-Exposed Patients with Diabetes Mellitus
por: Peng, Siping, et al.
Publicado: (2022) -
Lipohypertrophy in Individuals with Type 2 Diabetes: Prevalence and Risk Factors
por: Sürücü, Hamdiye Arda, et al.
Publicado: (2018) -
Prevalence of Lipohypertrophy and its Associations in Insulin-Treated Diabetic Patients
por: Nawaz, Arsalan, et al.
Publicado: (2023) -
A Systematic Survey of Physicians' Insights Into Lipohypertrophy
por: Shen, Min, et al.
Publicado: (2021)